Polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as a potential contrast agent for magnetic resonance imaging: Particle stability in biologic fluids

Investigative Radiology

Volumn 33, Issue 12, 1998, Pages 847-852

  Fallis, Stephen ^a   Beaty Nosco, Julie ^a   Dorshow, Richard B ^a   Adzamli, Kofi ^a  

^a MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

Magnetic resonance contrast media; Manganese; Metal substituted hydroxylapatite; Plasma stability

Indexed keywords

HYDROXYAPATITE; MACROGOL; MANGANESE DERIVATIVE;

ARTICLE; BLOOD; BODY FLUID; CATTLE; DRUG FORMULATION; DRUG STABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PLASMA; PRIORITY JOURNAL; RABBIT;

EID: 0032471054     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199812000-00001     Document Type: Article

References (13)

1. Adzamli K, Dorshow RB, Hynes MR, et al. Characterization of new RES-directed MRI agents. Proc Soc Magn Reson 1994, San Francisco, CA;897.
2. Adzamli K, Dorshow RB, Hynes MR, Nosco DL, Adams MD. PEG-coated Mn-substituted hydroxylapatites as potential MR contrast media for the blood pool. Proc Soc Magn Reson 1995, Nice, France;1114.
3. Lauterbur PC, Mendonca Dias MH, Rudin AM. Augmentation of tissue water proton spin-lattice relaxation rates by addition of paramagnetic ions. In: Dutton PL, Leigh JS, Scarpa A, eds. Front Biol Energ, [Pap Int Symp] Academic Press, 1978;1:752-759.
4. Wolf GL, Baum L. Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and in the rabbit. Am J Radiol 1983;141:193-197.
5. Kang YS, Gore JC, Armitage IM. Studies of factors affecting the design of NMR contrast agents: Manganese in blood as a model system. Magn Reson Med 1984;1:396-409.
6. 2+: Rabbit liver and kidney. Magn Reson Med 1985;2:159-168.
7. Misselwitz B, Muhler A, Weinmann HJ. A toxicologic risk for using manganese complexes? A literature survey of existing data through several medical specialties. Invest Radiol 1995;30:611-620.
8. Jynge P, Brurok H, Asplund A, et al. Cardiovascular safety of MnD-PDP: Experience from ex vivo and in vivo animal experiments. In: Rinck PA, Muller RN, eds. New Developments in Contrast Agent Research, 4th Special Topic Seminar (1994). Mons, Belgium: European MR Foundation (Belgian Office), 1995.
9. Koenig SH, Brown III RD. In: Gupta RK, ed. NMR spectroscopy of cells and organisms. Boca Raton: CRC Press, 1987;75.
10. Boumans PWJM. Inductively coupled plasma emission spectroscopy. New York: Wiley, 1987.
11. Wyman J, Gill SJ. Binding and linkage. Mill Valley: University Science Books, 1990;33-62.
12. Dorshow RB, Adzamli IK, Nosco DL, Joslin FL. Characterization of colloidal manganese hydroxylapatite: A potential MR contrast agent. Bull Amer Physical Soc 1996;41:191.
13. 2+ Ions. Biochemistry 1977;16:3883-3896.